Bloomberg reporters, Anna Edney and Riley Griffin, bring to light in a recent Bloomberg Big Take article an intra-governmental battle over drug safety with the nation's pharmaceutical regulator seemingly doing everything it can to keep Americans in the dark.

Generic drugs have saved the US hundreds of billions of dollars each year. But in the face of major recalls, pervasive shortages and questions about quality, the White House, Congress and even the Defense Department have come to view vulnerabilities in the generic drug supply chain as a national security threat.

US Army Colonel Victor Suarez, who spent his career getting medications to military hospitals and combat troops, decided to take action. He asked Valisure to assess the quality of some common drugs, in large part because he doubted the Food and Drug Administration’s ability to police a supply chain now dominated by low-cost manufacturers in India and China.The preliminary results shocked Suarez. He found that some generic versions of one important drug — given to soldiers who’ve lost limbs in combat — might not work. They could even cause kidney failure and seizures.

View the full article via Bloomberg.

‍

Bloomberg reporters, Anna Edney and Riley Griffin, bring to light in a recent Bloomberg Big Take article an intra-governmental battle over drug safety with the nation's pharmaceutical regulator seemingly doing everything it can to keep Americans in the dark.

Generic drugs have saved the US hundreds of billions of dollars each year. But in the face of major recalls, pervasive shortages and questions about quality, the White House, Congress and even the Defense Department have come to view vulnerabilities in the generic drug supply chain as a national security threat.

US Army Colonel Victor Suarez, who spent his career getting medications to military hospitals and combat troops, decided to take action. He asked Valisure to assess the quality of some common drugs, in large part because he doubted the Food and Drug Administration’s ability to police a supply chain now dominated by low-cost manufacturers in India and China.The preliminary results shocked Suarez. He found that some generic versions of one important drug — given to soldiers who’ve lost limbs in combat — might not work. They could even cause kidney failure and seizures.

View the full article via Bloomberg.

‍